PUBLISHER: BCC Research | PRODUCT CODE: 1105258
PUBLISHER: BCC Research | PRODUCT CODE: 1105258
The global market for clinical chemistry analyzers was valued at $2.6 billion in 2021 and is estimated to grow from $2.7 billion in 2022 to $3.3 billion in 2027 with a compound annual growth rate (CAGR) of 4.5% for the period of 2022-2027.
The semi-automated segment of the global clinical chemistry analyzers market was valued at $1.79 billion in 2021 and is estimated to grow from $1.85 billion in 2022 to $2.26 billion in 2027 with a CAGR of 4.1% for the period of 2022-2027.
The fully automated segment of the global clinical chemistry analyzers market was valued at $814 million in 2021 and is estimated to grow from $853 million in2022 to $1.1 billion in 2027 with a CAGR of5.3% for the period of 2022-2027.
This report examines the current and forecast market potential for clinical chemistry analyzers, in terms of product, modality and end user.
By product, the market is segmented into semi-automated and fully automated analyzers. By modality, the market is segmented into benchtop, standalone and handheld/portable. By end user, the market is segmented into hospitals and clinics, diagnostic labs, research institutes and others.
By geography, the market has been segmented into Europe, North America, Asia-Pacific (APAC) and Rest of the World (RoW). Major countries analyzed include the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India and China. For market estimates, data is provided for 2021 as the base year, 2022, and the forecast through year-end 2027. Estimates are based on manufacturers' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.